Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Next thing we will hear

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Oct 26, 2023 9:44am

136 Views

Post# 35701873

RE:RE:RE:RE:Next thing we will hear

Have you unblocked me now coward? Are you kidding, have you seen my previous work? I love chatting with you idiots and I'll continue to rip you apart until buyout day. So settle in because if that's years from now, according to your kindergarten analysis, we have a long time to get to know each other.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China